What are the health benefits of FreeYU Energy Gummies?
Caffein and Exercise Performance
When it comes to boosting energy and improving physical performance, caffeine has long held its place as a go-to ingredient — and for good reason...
Why it matters:
- Helps reduce perceived exertion
- Enhances focus and reaction time
- Supports endurance and power output
- Works best when tailored to individual needs
Caffeine & Performance: A Science-Backed Approach
Cognitive Enhancements: Caffeine improves alertness, attention, and short-term cognitive performance. Most effective in fatigue or sleep-deprivation conditions.1
Physical Performance: Caffeine improves endurance and power, especially in high-intensity and sprinting exercises.2
Practical Considerations for Health Professionals
Effects vary based on tolerance, genetics, and sleep quality. Optimal dose: 3–6 mg per kg of body weight.3
Recommended Use
- Adults: 1 gummy in the morning as needed
- Max: 2 gummies in 24 hours
Contraindications & Precautions
- Not for children, pregnant or breastfeeding women
- Consult physician for heart or CNS conditions
- Avoid combining with other caffeine sources
Clinical Indications
- Fatigue and low energy
- Mental alertness and focus
- Performance enhancement
- Midday energy dips
FAQ for Health Professionals
It can cause physical dependence in some, but not addiction. Withdrawal symptoms are typically mild.
Yes, in moderate doses (≤400 mg/day for most adults). Monitor in people with heart or anxiety disorders.
It increases compliance, especially for those who dislike pills. Also more enjoyable and portable.
REFERENCES
1- McLellan et al. (2016). Caffeine: Cognitive, physical & occupational effects. Neuroscience & Biobehavioral Reviews, 71, 294–312. https://doi.org/10.1016/j.neubiorev.2016.09.001
2- Guest et al. (2021). Caffeine and exercise performance. Journal of the International Society of Sports Nutrition, 18(1). https://doi.org/10.1186/s12970-020-00383-4
3- Nehlig, A. (2010). Is caffeine a cognitive enhancer? Journal of Alzheimer’s Disease, 20(Suppl 1), S85–S94. https://doi.org/10.3233/JAD-2010-091315
